---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-073129"
form_type: "8-K"
ticker: "TRVI"
cik: "0001563880"
company_name: "Trevi Therapeutics, Inc."
filed_at: "2024-06-13T23:59:59+00:00"
generated_at: "2026-06-01T04:36:13.949138+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Trevi Therapeutics annual meeting results: all director nominees elected, auditor ratified

## Summary
- Dominick Colangelo re-elected as Class II director with 47.1M votes for (99.8% of votes cast).
- Edward Mathers re-elected with 32.7M for; David Meeker re-elected with 33.6M for.
- Ernst & Young ratified as independent auditor for FY2024 with 54.0M for (99.9% of votes cast).

## SEC filing metadata
- accession: 0000950170-24-073129
- form_type: 8-K
- ticker: TRVI
- cik: 0001563880
- company_name: Trevi Therapeutics, Inc.
- filed_at: 2024-06-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563880/000095017024073129/0000950170-24-073129-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563880/000095017024073129/trvi-20240613.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-073129
- JSON: https://secwatch.observer/filing/0000950170-24-073129.json
- Plain text: https://secwatch.observer/filing/0000950170-24-073129.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.